Findings and conclusions from CMV hyperimmune globulin treatment trials
To access this article, please choose from the options below
PII: S1386-6532(09)00414-4
doi:10.1016/j.jcv.2009.08.017
© 2009 Elsevier B.V. All rights reserved.
PII: S1386-6532(09)00414-4
doi:10.1016/j.jcv.2009.08.017
© 2009 Elsevier B.V. All rights reserved.